Pharmaxis Receives Negative Recommendation from PADAC
31st
Jan 13
Release Date: 31/01/2013 12:00am
Pharmaceutical company Pharmaxis (ASX: PXS) today announced it has received a negative recommendation from a Committee advising the US Food and Drug Administration (FDA) on the use of BronchitolĀ® for cystic fibrosis patients in the United States.
Ā
Categories: News and Media